Filmed at the 2017 EACTS Annual Meeting, Octavio Alfieri, David Adams, Vinay Bapat, Michael Borger, and Randy Martin discuss the current state and future of treatment for mitral and tricuspid valve disease.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Tricuspid valve disease
April 17, 2018
This video shows a right minithoracotomy for a complex mitral and tricuspid repair.
December 31, 2017
The Nationwide Inpatient Sample was evaluated to assess tricupsid valve surgery. Isolated and concurrent tricuspid surgery outcomes are analyzed. The authors conclude that "surgical treatment of TR remains underused and is associated with high operative morbidity and mortality, prolonged hospitalizations, and considerable cost."
August 18, 2017
Patient Care
Several private hospitals in Kolkata, India, have applied for licenses to perform heart and lung transplants in a region underserved for transplant of these organs.
June 20, 2017
David and colleagues investigate tricuspid regurgitation (TR) before and after mitral valve (MV) repair in a retrospective analysis of over 1000 patients. TR was present prior to surgery in 11.8% of cases and new postoperative TR was not common. The authors suggest that their findings support repairing the MV before TR develops.
June 12, 2017
Ejiofor, et al. present a retrospective analysis of the mid- and long-term outcomes following isolated tricuspid valve (TV) surgery in 57 adult patients, with overall operative mortality of 8.6% and similar mid-term outcomes for TV repair versus replacement.
June 6, 2016
This video demonstrates a tricuspid valve replacement with a mitral homograft in a child with endocarditis.
March 21, 2016
This French group retrospectively compared their experience with tricuspid valve replacements (n=188) using either tissue (82%) or mechanical (18%) valves during a >30-year period. Findings from the study included:
March 14, 2016
This video shows a tricuspid valve replacement in a patient with severe endocarditis.
March 7, 2016
Outcomes of tricuspid valve replacement at a single institution over a 4 decade period were reviewed. A bioprosthesis was used in 82%, and the surgical mortality was nearly 28%. Freedom from structural deterioration was better in the mechanical valve group. Mechanical valves were, however, associated with earlier and more severe morbidity, includi